Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Finance
The Pharmaceutical Market: Mozambique

Mozambique pharmaceutical market: Latest market analysis presented


Print article Print article
© companiesandmarkets.com

companiesandmarkets.com
companiesandmarkets.com
2014-03-13 15:03:03 - The Pharmaceutical Market: Mozambique - a new market research report on companiesandmarkets.com

Mozambique relies on drug imports to supply the majority of its domestic demand, but sinc e July 2012, has started limited national production of antiretrovirals at the state-owned Sociedade Moçambicana de Medicamentos (SMM). Supported by Brazil´s Farmanguinhos, Mozambicans travelled to Brazil in October 2012 as part of a technology transfer agreement until Mozambique can manufacture over 20 types of basic drugs. While urban areas are experience considerable improvements to healthcare, rural and isolated areas lag behind , where investment in healthcare infrastructure and human capital is required. With rich natural resources and a stable political environment, Mozambique is an attractive market for international investors; BMI forecasts that full year real GDP growth will reach 7.5% in 2012.

Headline Expenditure Forecasts

Pharmaceuticals: MZN2.32bn

 

 

(US$80mn) in 2011 to MZN2.51bn (US$89mn) in 2012; +8.5% in local currency and +12.3% in US dollar terms.

Healthcare: MZN19.28bn (US$661mn) in 2011 to MZN21.86bn (US$779mn) in 2012; +13.8% in local currency and +17.8% in US dollar terms.

Risk/Reward Rating

Mozambique scores 36.1 out of 100 in the Q113 Pharmaceutical Risk/Reward Ratings (RRRs) and ranks 25th of the 30 countries surveyed in BMI´s Middle East and Africa (MEA) regional ratings. Mozambique has a below-average score in all categories, with its Country Rewards score posting the highest performance.

Competitive Landscape

The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.


Author:
Mike King
e-mail
Web: www.companiesandmarkets.com
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com